Akero Therapeutics's market cap is currently $3.80B. The company's EPS TTM is $-3.746; its P/E ratio is ―; Akero Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-1.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -29.00K	$ -260.00K	$ -244.00K	$ -213.00K	$ 0.00
Operating Income	$ -172.87M	$ -115.16M	$ -100.89M	$ -80.15M	$ -45.65M
EBITDA	$ -148.63M	$ -111.03M	$ -100.53M	$ -78.99M	$ -45.65M
Net Income	$ -151.76M	$ -108.91M	$ -100.74M	$ -79.19M	$ -43.76M
Balance Sheet
Cash & Short-Term Investments	$ 550.01M	$ 351.45M	$ 188.26M	$ 268.39M	$ 136.40M
Total Assets	$ 580.27M	$ 356.57M	$ 195.55M	$ 273.34M	$ 138.12M
Total Debt	$ 26.30M	$ 10.95M	$ 1.52M	$ 1.81M	$ 0.00
Net Debt	$ -207.90M	$ -238.83M	$ -148.97M	$ -185.43M	$ -136.40M
Total Liabilities	$ 44.97M	$ 30.01M	$ 26.44M	$ 14.63M	$ 9.39M
Stockholders' Equity	$ 535.31M	$ 326.56M	$ 169.11M	$ 258.71M	$ 128.73M
Cash Flow
Free Cash Flow	$ -145.37M	$ -92.52M	$ -79.68M	$ -70.95M	$ -35.63M
Operating Cash Flow	$ -145.37M	$ -92.52M	$ -79.68M	$ -70.80M	$ -35.63M
Investing Cash Flow	$ -223.62M	$ -63.83M	$ 42.28M	$ -9.76M	$ -71.51M
Financing Cash Flow	$ 353.32M	$ 255.63M	$ 602.00K	$ 203.11M	$ 95.99M

Currency in USD

Akero Therapeutics Earnings and Revenue History

Income Statement >

Akero Therapeutics Debt to Assets

Balance Sheet >

Akero Therapeutics Cash Flow

Cash Flow >

Akero Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing